Industries > Pharma > Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029

Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029

High-Field MRI, Ultra-High Field MRI, Low-Field MRI

PUBLISHED: 08 January 2019
PAGES: 155
PRODUCT CODE: PHA0350
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0350 Categories: , Tags: ,

The global magnetic resonance imaging (MRI) systems market is expected to grow at a CAGR of 6.5% in the first half of the forecast period. In 2018, the high-field segment held 60% share of the global magnetic resonance imaging (MRI) systems.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 155-page report you will receive 108 charts – all unavailable elsewhere.

The 155-page report provides clear detailed insight into the global magnetic resonance imaging market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Magnetic Resonance Imaging (MRI) Systems Market forecast from 2019-2029

• Global Magnetic Resonance Imaging (MRI) Systems market forecast by field strength:
• High-Field MRI
• Ultra-High Field MRI
• Low-Field MRI

• Global Magnetic Resonance Imaging (MRI) Systems by National Market forecast 2019-2029, covering:
• US
• Japan
• Germany
• France
• The UK
• Italy
• Spain
• China
• India
• Brazil
• Russia
• Rest of the World (RoW)

Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029

Each national market forecast is further segmented by field strength.

• Assessment of selected leading companies that are the main players in the magnetic resonance imaging (MRI) systems market:
• Aurora Healthcare US Corp
• Bruker Corporation
• Canon Medical Systems
• Esaote SpA
• GE Healthcare
• Hitachi, Ltd.
• Neusoft Medical Systems Co., Ltd.
• Philips Healthcare
• Shenzhen Anke High-tech Co., Ltd.
• Siemens Healthineers

• This report provides a SWOT and STEP analysis of the global magnetic resonance imaging (MRI) systems market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Magnetic Resonance Imaging (MRI) Systems Market. You find data, trends and predictions.

Buy our report today Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029: High-Field MRI, Ultra-High Field MRI, Low-Field MRI

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2019-2029


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category